Litcius/Paper detail

A real-world study of the efficacy and safety of anti-PD-1 antibodies plus lenvatinib in patients with advanced gallbladder cancer

Bangyou Zuo, Xiaobo Yang, Xu Yang, Jin‐Song Bian, Junyu Long, Dongxu Wang, Cong Ning, Yanyu Wang, Ziyu Xun, Yunchao Wang, Xin Lu, Yilei Mao, Xinting Sang, Haitao Zhao

2022Cancer Immunology Immunotherapy25 citationsDOIOpen Access PDF

Topics & Concepts

LenvatinibMedicineInternal medicineAdverse effectGallbladder cancerGastroenterologyCancerOncologySurgeryThyroid cancerCholangiocarcinoma and Gallbladder Cancer StudiesBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers